Duncan McKechnie, EVP, Chief Commercial Officer: Vertex Pharmaceuticals VRTX Sell · Filed 03/13

Trade details

Type: Insider sale
Amount: $1,312,339.86
Shares · price: 2,633 sh · $498.42 a share
Held after: 12,489 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Duncan McKechnieEVP, Chief Commercial Officer
Trade date: 26/03/11
Filed: 26/03/13
Days to filing: 2 days

Sold 17.4% of holdings

Share of holding sold: 17.4%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/09~04/10

Duncan McKechnie's recent trades

Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$799.8K
1,541 sh
$799.8K
Filed 07/02
Traded 07/02
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.3M
2,633 sh
$1.3M
Filed 03/11
Traded 03/11
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/06
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,437 sh
$1.2M
Filed 03/04
Traded 03/04
Duncan McKechnieEVP, Chief Commercial Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.2M
2,500 sh
$1.2M
Filed 02/26
Traded 02/25